Monteaguado SB, Mariño A, Cabanillas M, Varela M

Language: Spanish
References: 17
Page: 134-135
PDF size: 75.24 Kb.

Text Extraction

REFERENCES

1. Martin Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García Samaniego J et al. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. AIDS 2008; 22: 15-21.

2. Marcos Sánchez F, Albo Castaño MI, Martín Barranco MJ, Casallo Blanco S, Joya Seijo D, Del Valle Loarte P. Dificultades en la selección de pacientes coinfectados por el VIH para recibir tratamiento contra el virus de la hepatitis C. Gastroenterol Hepatol 2005; 28: 361-4.

3. Merino Rodríguez B, Díaz Sánchez A, Matilla Peña A, Clemente Ricote G, Núñez Martínez O. Trombosis portal aguda en pacientes con hepatitis C crónica en tratamiento con interferón pegilado y ribavirina. Gastroenterol Hepatol 2008; 31: 18-21.

4. Herrero Mateu C, Moreno Romero JA, Guilabert Vidal A. Tratamiento dermatológico en pacientes con hepatitis C. Piel 2006; 21: 135-41.

5. Álvarez Cuesta CC, Blanco S, Rodríguez Díaz E, Galache C, Martínez Merino A. Granulomas sarcoideos cutáneos desarrollados alrededor de cuerpos extraños durante el tratamiento con interferón y ribavirina en un paciente con hepatitis C crónica. Actas Dermosifiliogr 2003; 94: 655-9.

6. Manjón Haces JA, Vázquez López F, Gómez Díez S, Hidalgo García A, Pérez Álvarez R, Soler Sánchez T et al. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 2001; 81: 223.

7. Gurguta C, Kauer C, Bergholz U, Formann E, Steindl Munda P, Ferenci P. Tongue and skin hyperpigmentation during PEGinterferon- /ribavirin therapy in darkskinned non-caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006; 101: 197-8.

8. Ruiz de Casas A, García Bravo B, Camacho F. Eczema generalizado secundario a tratamiento combinado con interferón alfa-2a pegilado y ribavirina en un paciente con hepatitis crónica por virus de la hepatitis C. Actas Dermosifiliogr 2005; 96: 122-3.

9. Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon alfa-2b and ribavirin combination therapy for hepatitis C infection. Arch Dermatol 2005; 141: 102-3.

10. Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004; 140: 215-7.

11. Hashimoto Y, Kanto H, Itoh M. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. J Dermatol 2007; 34: 577-82.

12. Dereure O, Raison Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147: 1142-6.

13. Conde Taboada A, de la Torre C, Feal C, Mayo E, González Sixto B, Cruces MJ. Meyerson`s naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection. Br J Dermatol 2005; 153: 1070-2.

14. Girard C, Bessis D, Blatière V, Guilhou JJ, Guillot B. Meyerson`s phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection. Br J Dermatol 2005; 152: 182-3.

15. Monteagudo Sánchez B, Ginarte Val M, Carballal Mariño M, Monteagudo Campos JL. Fenómeno de Meyerson. Piel 2005; 20: 306-7.

16. Vázquez López F, Manjón Haces JA, PérezÁlvarez R, Pérez Oliva N. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment. Br J Dermatol 2004; 150: 1046-7.

17. Kerl L, Negro F, Lübbe J. Cutaneous sideeffects of treatment of chronic hepatitis C by interferon alfa and ribavirin. Br J Dermatol 2003; 149: 556. Med Cutan Iber Lat Am 2010;38(3):134-135 135 Cartas al Director